The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesJames W. Vardiman, Clara D. Bloomfield, Jüergen Thiele et al.|Blood|2009Cited by 4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Martha Wadleigh et al.|Cancer Cell|2005Cited by 3k
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosisAyalew Tefferi, Alessandro M. Vannucchi|Blood|2014Cited by 722
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyAyalew Tefferi, Tiziano Barbui|Leukemia|2013Cited by 666
The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussionTiziano Barbui, Ayalew Tefferi|Blood Cancer Journal|2018Cited by 632